Hip Fractures No Longer on a Downward Trend in the U.S.
Osteoporosis-related hip fractures are no longer on a downward trend in the U.S. A drop in reimbursement for a common screening technique could be to blame.
How One Class of Bisphosphonates Could Predict Vertebral Fractures
Using biomarkers to assess drug efficacy could pave the way for improved osteoporosis treatment, according to a new study.
Screening is Lax in Glucocorticoid-Induced Osteoporosis
Some patients are not being screened or treated for glucocorticoid-induced osteoporosis by primary care physicians or rheumatologists.
Researchers Aim to Clarify Vitamin D Supplementation
Should you prescribe Vitamin D to your patient to prevent fractures? If so, how much?
Osteoporosis Risk for Rheumatoid Arthritis Patients
Osteoporosis is undertreated with only half of patients who qualify for a diagnosis receiving treatment. There are particular considerations for patients with rheumatologic illness.
Bone Changes Do Occur in PsA, Study Shows
Systemic bone loss can occur in psoriatic arthritis, but it doesn’t always show up using traditional scanning methods, new research finds.
A Review of Bisphosphonates for Osteoporosis
Evidence-based medicine and patient input needed in prescribing bisphosphonates for osteoporosis.
By clicking Accept, you agree to become a member of the UBM Medica Community.